Novel coronavirus nucleocapsid protein (novel coronavirus N protein)

タイトルまたは説明

Novel coronavirus nucleocapsid protein (novel crown virus N protein, ****-nCoV N protein)
****-nCoV is a novel coronavirus discovered at the end of ***9, which is highly infectious. Its proteins are divided into: spike glycoprotein (S protein), envelope glycoprotein (E protein), membrane glycoprotein (M protein), and nucleocapsid protein (N protein). N protein and viral genome RNA intertwine to form viral nucleocapsid, which plays an important role in the synthesis of viral RNA. At the same time, N protein is relatively conservative, which accounts for the largest proportion in the structural protein of the virus. In the early stage of infection, the body can produce a high level of anti-N protein antibody. The N protein can be used to establish a rapid detection method of anti*****-ncov serum antibody. It can also be used to further prepare monoclonal antibodies or carry out research on the structure of the protein.
The novel coronavirus N protein (full length) provided by our company is a recombinant product with high immunogenicity and good stability.
[Product Description]
Dosage form: lyophilized powder or solution
Source: microbial recombinant protein
Molecular weight: about *0 KD (detected by SDS-PAGE)
Purity: ≥*0% (SDS-PAGE detection)
Preservation solution: 0.*1M PBS, pH 7.4
Transportation conditions: low temperature
Stability and storage: from th          e date of receipt, it can be stable for *2 months at - *0 ℃ to - *0 ℃. Upon receipt, store at - *0 ℃ to - *0 ℃ in sterile condition. It is recommended that the protein be equally divided into smaller amounts for optimal storage. Avoid repeated freeze-thaw cycles.
Safety note: this reagent is only used for research and development or production, and it is strictly prohibited to be used in human experiments